Advanced Therapies Congress 2022, London

24-25 May 2022, London, UK

ViroCell Biologics is attending Advanced Therapies Congress to connect with our partners and clients.

If you are working towards a clinical program, or need near-term GMP manufacturing slots, please contact Gavin Allsop on LinkedIn or through the networking app.

ViroCell is a London-based CDMO specializing in the GMP manufacture of γ-retro, Lenti and AAV vectors. Team ViroCell’s extensive prior track record includes the manufacture and delivery of over 130 batches of GMP vector used in clinical trials around the world.

Team ViroCell’s deep prior experience also includes supporting innovators in vector design & optimization, pre-clinical studies, and initial and follow-on regulatory submissions. 

ViroCell is taking orders now for manufacturing at our state-of-the-art clean room facility in London for Q4 2022 and 2023. ViroCell aims to deliver QP-released product within six months of starting your GMP manufacturing campaign. Please let us know if we can help accelerate your CGT product candidate into clinical trials.

#advancedtherapies #advancedtherapies2022 #clinicaltrials #cellandgene #viralvector #viralvectors  #celltherapy #celltherapies #genetherapy #CDMO